Soerensen Charlotte M, Holmskov Uffe, Aalbaek Bent, Boye Mette, Heegaard Peter M, Nielsen Ole L
Department of Veterinary Pathobiology, Laboratory of Pathology, The Royal Veterinary Agricultural University, Frederiksberg, Denmark.
Immunology. 2005 Aug;115(4):526-35. doi: 10.1111/j.1365-2567.2005.02189.x.
Surfactant protein D (SP-D) is a pattern-recognition molecule of the innate immune system that recognizes various microbial surface-specific carbohydrate and lipid patterns. In vitro data has suggested that this binding may lead to increased microbial association with macrophages and dendritic cells. The aim of the present in vivo study was to study the expression of porcine SP-D (pSP-D) in the lung during different pulmonary bacterial infections, and the effect of the routes of infection on this expression was elucidated. Furthermore, the aim was to study the in vivo spatial relationship among pSP-D, pathogens, phagocytic cells and dendritic cells. Lung tissue was collected from experimental and natural bronchopneumonias caused by Actinobacillus pleuropneumoniae or Staphylococcus aureus, and from embolic and diffuse interstitial pneumonia, caused by Staph. aureus or Arcanobacterium pyogenes and Streptococcus suis serotype 2, respectively. By comparing normal and diseased lung tissue from the same lungs, increased diffuse pSP-D immunoreactivity was seen in the surfactant in both acute and chronic bronchopneumonias, while such increased expression of pSP-D was generally not present in the interstitial pneumonias. Co-localization of pSP-D, alveolar macrophages and bacteria was demonstrated, and pSP-D showed a patchy distribution on the membranes of alveolar macrophages. SP-D immunoreactivity was intracellular in dendritic cells. The dendritic cells were identified by their morphology, the absence of macrophage marker immunoreactivity and the presence of dendritic cell marker immunoreactivity. Increased expression of pSP-D in the surfactant coincided with presence of pSP-D-positive dendritic cells in bronchus-associated lymphoid tissue (BALT), indicating a possible transport of pSP-D through the specialized M cells overlying (BALT). In conclusion, we have shown that pSP-D expression in the lung surfactant is induced by bacterial infection by an aerogenous route rather than by a haematogenous route, and that the protein interacts specifically with alveolar macrophages and with dendritic cells in microbial-induced BALT. The function of the interaction between pSP-D and dendritic cells in BALT remain unclear, but pSP-D could represent a link between the innate and adaptive immune system, facilitating the bacterial antigen presentation by dendritic cells in BALT.
表面活性蛋白D(SP-D)是先天性免疫系统的一种模式识别分子,可识别各种微生物表面特异性碳水化合物和脂质模式。体外数据表明,这种结合可能导致微生物与巨噬细胞和树突状细胞的关联增加。本体内研究的目的是研究猪SP-D(pSP-D)在不同肺部细菌感染期间在肺中的表达,并阐明感染途径对该表达的影响。此外,目的是研究pSP-D、病原体、吞噬细胞和树突状细胞之间的体内空间关系。从由胸膜肺炎放线杆菌或金黄色葡萄球菌引起的实验性和自然支气管肺炎,以及分别由金黄色葡萄球菌或化脓隐秘杆菌和2型猪链球菌引起的栓塞性和弥漫性间质性肺炎中采集肺组织。通过比较同一肺的正常和患病肺组织,在急性和慢性支气管肺炎的表面活性剂中均可见弥漫性pSP-D免疫反应性增加,而在间质性肺炎中通常不存在pSP-D的这种表达增加。证实了pSP-D、肺泡巨噬细胞和细菌的共定位,并且pSP-D在肺泡巨噬细胞膜上呈斑片状分布。SP-D免疫反应性在树突状细胞内。通过其形态、巨噬细胞标志物免疫反应性的缺失和树突状细胞标志物免疫反应性的存在来鉴定树突状细胞。表面活性剂中pSP-D表达的增加与支气管相关淋巴组织(BALT)中pSP-D阳性树突状细胞的存在一致,表明pSP-D可能通过覆盖在(BALT)上的特化M细胞转运。总之,我们已经表明,肺表面活性剂中的pSP-D表达是由气源性途径而非血源性途径的细菌感染诱导的,并且该蛋白与肺泡巨噬细胞以及微生物诱导的BALT中的树突状细胞特异性相互作用。pSP-D与BALT中树突状细胞之间相互作用的功能仍不清楚,但pSP-D可能代表先天性和适应性免疫系统之间的联系,促进BALT中树突状细胞的细菌抗原呈递。